Essex Investment Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-238,877
Closed -$2.15M 324
2025
Q2
$2.15M Buy
+238,877
New +$1.42M 0.39% 101
2020
Q4
Sell
-177,232
Closed -$1.05M 514
2020
Q3
$1.05M Buy
177,232
+5,775
+3% +$37.9K 0.15% 209
2020
Q2
$1.2M Sell
171,457
-836
-0.5% -$6.11K 0.2% 164
2020
Q1
$896K Sell
172,293
-9,059
-5% -$62K 0.18% 169
2019
Q4
$1.34M Buy
181,352
+8,539
+5% +$70.8K 0.16% 199
2019
Q3
$1.5M Sell
172,813
-19,827
-10% -$170K 0.22% 152
2019
Q2
$1.53M Buy
192,640
+27,714
+17% +$252K 0.21% 164
2019
Q1
$1.69M Sell
164,926
-5,660
-3% -$50.8K 0.25% 128
2018
Q4
$1.15M Sell
170,586
-11,431
-6% -$83.1K 0.18% 171
2018
Q3
$1.48M Buy
182,017
+74,688
+70% +$698K 0.17% 175
2018
Q2
$1.03M Sell
107,329
-8,798
-8% -$84.3K 0.13% 220
2018
Q1
$1.16M Sell
116,127
-8,840
-7% -$68.4K 0.15% 192
2017
Q4
$819K Buy
124,967
+12,639
+11% +$84.8K 0.11% 231
2017
Q3
$758K Sell
112,328
-2,570
-2% -$17.5K 0.1% 231
2017
Q2
$827K Buy
+114,898
New +$704K 0.12% 221

Other funds holding ULBI

Essex Investment Management's ULBI Position: Q3 2025 in Review

Essex Investment Management sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 238,877 shares — an estimated $2.15M sold.

Essex Investment Management first reported a position in ULBI in Q2 2017 and held it in 15 quarters. The position peaked at $2.15M in Q2 2025. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Essex Investment Management reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Essex Investment Management sold 238,877 Ultralife shares in Q3 2025, an estimated $2.15M.
  • Essex Investment Management first reported a position in Ultralife in Q2 2017 and held it in 15 quarters.
  • Essex Investment Management's Ultralife position peaked at $2.15M in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Essex Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.